Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AZ's COVID-19 Antibody Combo Protects For Longer But Access Issues Persist

Positive Clinical Update On Evusheld

21 Apr 2022

• By Kevin Grogan

AstraZeneca — • Source: Shutterstock: Elzbieta Krzysztof

Related Content

AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19

24 Mar 2022

AstraZeneca Focuses On COVID-19 Antibody Approach After Year Of Vaccine Headwinds

10 Feb 2022

Related Companies

AstraZeneca PLC

Additional Topics

Coronavirus COVID-19 Clinical Trials Market Access Business Strategies Research & Development BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.